Clara Albani
Overview
Explore the profile of Clara Albani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
128
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albani C, Pensel P, Fabbri J, Albanese A, Paladini A, Elissondo M
Exp Parasitol
. 2022 Nov;
244:108430.
PMID: 36435216
Cystic echinococcosis is a worldwide zoonotic disease caused by Echinococcus granulosus sensu lato (s.l.), which produces serious health and economic problems. For human treatment, chemotherapy with albendazole (ABZ), a derivative...
2.
De Vita T, Albani C, Realini N, Migliore M, Basit A, Ottonello G, et al.
ACS Chem Neurosci
. 2018 Nov;
10(3):1627-1635.
PMID: 30481470
Alzheimer's disease (AD) is a slow-progressing disease of the brain characterized by symptoms such as impairment of memory and other cognitive functions. AD is associated with an inflammatory process that...
3.
Klupsch K, Baeriswyl V, Scholz R, Dannenberg J, Santimaria R, Senn D, et al.
Leukemia
. 2018 Sep;
33(3):805-808.
PMID: 30206306
No abstract available.
4.
Polacchini A, Albani C, Baj G, Colliva A, Carpinelli P, Tongiorgi E
Biol Open
. 2016 Jun;
5(7):899-907.
PMID: 27256407
Drug-resistance to chemotherapics in aggressive neuroblastoma (NB) is characterized by enhanced cell survival mediated by TrkB and its ligand, brain-derived neurotrophic factor (BDNF); thus reduction in BDNF levels represent a...
5.
Migliore M, Habrant D, Sasso O, Albani C, Bertozzi S, Armirotti A, et al.
Eur J Med Chem
. 2016 Jan;
109:216-37.
PMID: 26774927
Non-steroidal anti-inflammatory drugs (NSAIDs) exert their pharmacological effects by inhibiting cyclooxygenase (COX)-1 and COX-2. Though widely prescribed for pain and inflammation, these agents have limited utility in chronic diseases due...
6.
Sasso O, Migliore M, Habrant D, Armirotti A, Albani C, Summa M, et al.
FASEB J
. 2015 Mar;
29(6):2616-27.
PMID: 25757568
The ability of nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit cyclooxygenase (Cox)-1 and Cox-2 underlies the therapeutic efficacy of these drugs, as well as their propensity to damage the gastrointestinal (GI)...
7.
Colombano G, Albani C, Ottonello G, Ribeiro A, Scarpelli R, Tarozzo G, et al.
ChemMedChem
. 2014 Oct;
10(2):380-95.
PMID: 25338703
Inhibition of fatty acid amide hydrolase (FAAH) activity is under investigation as a valuable strategy for the treatment of several disorders, including pain and drug addiction. A number of potent...
8.
De Simone A, Ruda G, Albani C, Tarozzo G, Bandiera T, Piomelli D, et al.
Chem Commun (Camb)
. 2014 Apr;
50(38):4904-7.
PMID: 24691497
Combining computer-assisted drug design and synthetic efforts, we generated compounds with potent and balanced activities toward both D3 dopamine receptor and fatty acid amide hydrolase (FAAH) enzyme. By concurrently modulating...
9.
Bertolacci L, Romeo E, Veronesi M, Magotti P, Albani C, Dionisi M, et al.
J Am Chem Soc
. 2012 Dec;
135(1):22-5.
PMID: 23240907
In addition to inhibiting the cyclooxygenase (COX)-mediated biosynthesis of prostanoids, various widely used nonsteroidal anti-inflammatory drugs (NSAIDs) enhance endocannabinoid signaling by blocking the anandamide-degrading membrane enzyme fatty acid amide hydrolase...
10.
Favia A, Habrant D, Scarpelli R, Migliore M, Albani C, Bertozzi S, et al.
J Med Chem
. 2012 Oct;
55(20):8807-26.
PMID: 23043222
Pain and inflammation are major therapeutic areas for drug discovery. Current drugs for these pathologies have limited efficacy, however, and often cause a number of unwanted side effects. In the...